Lamotrigine add-on for refractory generalized tonic-clonic seizures

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Tjia Leong, Eugene ^a   Leong, Kevin ^b   Marson, Anthony ^c  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Brighton Health Care NHS Trust   (United Kingdom)

^c Departments of Neurology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; PLACEBO; CARBAMAZEPINE; OXCARBAZEPINE; PHENYTOIN; VALPROIC ACID;

ADD ON THERAPY; ATAXIA; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; DIPLOPIA; DIZZINESS; DRUG EFFECT; DRUG WITHDRAWAL; FATIGUE; FOLLOW UP; HUMAN; MYOCLONUS EPILEPSY; NAUSEA; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SENSITIVITY ANALYSIS; SOMNOLENCE; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HEADACHE; MYOCLONUS SEIZURE;

EID: 70349119574     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007783     Document Type: Review

References (10)

1. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet. 1995 Jul 15;346(8968):140-144
2. Fitton A, Goa LK. Lamotrigine: An Update of its pharmacotherapy and therapeutic use in epilepsy. Drugs 1995;50:691-713.
3. Anonymous. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-399
4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports or randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12. (Pubitemid 26120810)
5. Kwan P, Brodie MJ. Early identification of refractory epilepsy. New England Journal of Medicine 2000;342(5):314-319
6. Leach LJ, Lees G, Riddall DR. Lamotrigine. Mechanisms of action in antiepileptic drugs. 4th Edition. New York: Raven Press, 1995.
7. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al.The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-1026 (Pubitemid 46436125)
8. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug resistant partial epilepsy. Cochrane Database of Systematic Reviews 2001, Issue 3.
9. Sander JW, Shorvon SD. Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 1996;61(5):433-443
10. Weintraub D, Buchsbaum R, Resor SR Jr, Hirsch LJ. Effect of antiepileptic drug comedication on lamotrigine clearance. Archives of Neurology 2005 Sep;62(9):1432-1436 (Pubitemid 41352061)